World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3431)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-4) series.

Item

Count

PDF

HTML

2427

Figures (1-9)

197

Tables (1-4)

198

Sum=2886

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

117

Download

251

Sum=368

Apr 7, 2024 (publication date) through Oct 31, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Kojima K, Watanabe K, Kawai M, Yagi S, Kaku K, Ikenouchi M, Sato T, Kamikozuru K, Yokoyama Y, Takagawa T, Shimizu M, Shinzaki S. Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis. World J Gastroenterol 2024; 30(13): 1871-1886 [PMID: 38659488 DOI: 10.3748/wjg.v30.i13.1871]
URL:	https://www.wjgnet.com/2220-315x/full/v30/i13/1871.htm

Number	Citing Articles
1	Sara R Lopes, Claudio Martins, Madalena Teixeira, David Tomás. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis. World Journal of Gastroenterology 2024; 30(34): 3929-3931 doi: 10.3748/wjg.v30.i34.3929 Abstract(86) \| Core Tip(99) \| Full Article(HTML)(479) \| Full Article with Cover (PDF)-563K(17) \| Audio-100K(6) \| Peer-Review Report-223K(15) \| Answering Reviewers-43K(15) \| Full Article (PDF)-338K(49) \| Full Article (XML)-34K(15) \| Times Cited (0) \| Total Visits (975) \| Open
2	Tofacitinib. Reactions Weekly 2024; 2007(1): 321 doi: 10.1007/s40278-024-58881-4
3	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(93) \| Core Tip(95) \| Full Article(HTML)(282) \| Full Article with Cover (PDF)-639K(19) \| Audio-785K(3) \| Peer-Review Report-230K(14) \| Answering Reviewers-209K(14) \| Full Article (PDF)-410K(24) \| Full Article (XML)-117K(15) \| Times Cited (0) \| Total Visits (830) \| Open
4	Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942 Abstract(99) \| Core Tip(87) \| Full Article(HTML)(1292) \| Full Article with Cover (PDF)-2954K(33) \| Audio-1388K(2) \| Peer-Review Report-220K(17) \| Answering Reviewers-74K(16) \| Full Article (PDF)-2682K(120) \| Full Article (XML)-189K(14) \| Times Cited (0) \| Total Visits (1998) \| Open
5	D. I. Trukhan. Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects. Meditsinskiy sovet = Medical Council 2024; (15): 200 doi: 10.21518/ms2024-344
6	Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment option. World Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386 Abstract(44) \| Core Tip(46) \| Full Article(HTML)(276) \| Full Article with Cover (PDF)-796K(12) \| Audio-1114K(1) \| Peer-Review Report-175K(7) \| Answering Reviewers-254K(11) \| Full Article (PDF)-461K(17) \| Full Article (XML)-92K(7) \| Times Cited (0) \| Total Visits (584) \| Open